ArticleCancers2022

Risk of Thromboembolic Events and Major Adverse Cardiovascular Events Following Antivascular Endothelial Growth Factor Therapy in Patients with Colorectal Cancer.

Yen-Cheng Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.